Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jodi M Carter

Showing results (81-90 of 115) with videos related to

Pageof 12
Sort By:
Scientific Reports|December 31, 2022
Immune cell populations differ in patients undergoing revision total knee arthroplasty for arthrofibrosisAfton K Limberg, Christopher G Salib, Meagan E Tibbo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 24, 2023
Trimodality Therapy Improves Disease Control in Radiation-Associated Angiosarcoma of the BreastAmy C Degnim, Brittany L Siontis, Safia K Ahmed, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2017
Alterations in the Immune Cell Composition in Premalignant Breast Tissue that Precede Breast Cancer DevelopmentAmy C Degnim, Tanya L Hoskin, Muhammad Arshad, et al.
The Journal of Clinical Investigation|July 7, 2026
ATR senses stiff extracellular matrix to promote epithelial-to-mesenchymal transition and immune suppressionXinyi Tu, Xiangyu Zeng, Yaoliang Sun, et al.
Nature Communications|January 27, 2022
Mapping molecular subtype specific alterations in breast cancer brain metastases identifies clinically relevant vulnerabilitiesNicola Cosgrove, Damir Varešlija, Stephen Keelan, et al.
The Journal of Pathology|October 17, 2014
Identification of a novel FN1-FGFR1 genetic fusion as a frequent event in phosphaturic mesenchymal tumourJen-Chieh Lee, Yung-Ming Jeng, Sheng-Yao Su, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 10, 2021
Characteristics and Spatially Defined Immune (micro)landscapes of Early-stage PD-L1-positive Triple-negative Breast CancerJodi M Carter, Mei-Yin C Polley, Roberto A Leon-Ferre, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 21, 2018
Model for Predicting Breast Cancer Risk in Women With Atypical HyperplasiaAmy C Degnim, Stacey J Winham, Ryan D Frank, et al.
Oncogene|March 6, 2021
Aurora-A kinase oncogenic signaling mediates TGF-β-induced triple-negative breast cancer plasticity and chemoresistanceMohammad Jalalirad, Tufia C Haddad, Jeffrey L Salisbury, et al.
NPJ Breast Cancer|January 20, 2022
Automated quantification of levels of breast terminal duct lobular (TDLU) involution using deep learningThomas de Bel, Geert Litjens, Joshua Ogony, et al.
Pageof 12

Showing results (81-90 of 115) with videos related to

Sort By:
Pageof 12
Scientific Reports|December 31, 2022
Immune cell populations differ in patients undergoing revision total knee arthroplasty for arthrofibrosisAfton K Limberg, Christopher G Salib, Meagan E Tibbo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 24, 2023
Trimodality Therapy Improves Disease Control in Radiation-Associated Angiosarcoma of the BreastAmy C Degnim, Brittany L Siontis, Safia K Ahmed, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2017
Alterations in the Immune Cell Composition in Premalignant Breast Tissue that Precede Breast Cancer DevelopmentAmy C Degnim, Tanya L Hoskin, Muhammad Arshad, et al.
The Journal of Clinical Investigation|July 7, 2026
ATR senses stiff extracellular matrix to promote epithelial-to-mesenchymal transition and immune suppressionXinyi Tu, Xiangyu Zeng, Yaoliang Sun, et al.
Nature Communications|January 27, 2022
Mapping molecular subtype specific alterations in breast cancer brain metastases identifies clinically relevant vulnerabilitiesNicola Cosgrove, Damir Varešlija, Stephen Keelan, et al.
The Journal of Pathology|October 17, 2014
Identification of a novel FN1-FGFR1 genetic fusion as a frequent event in phosphaturic mesenchymal tumourJen-Chieh Lee, Yung-Ming Jeng, Sheng-Yao Su, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 10, 2021
Characteristics and Spatially Defined Immune (micro)landscapes of Early-stage PD-L1-positive Triple-negative Breast CancerJodi M Carter, Mei-Yin C Polley, Roberto A Leon-Ferre, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 21, 2018
Model for Predicting Breast Cancer Risk in Women With Atypical HyperplasiaAmy C Degnim, Stacey J Winham, Ryan D Frank, et al.
Oncogene|March 6, 2021
Aurora-A kinase oncogenic signaling mediates TGF-β-induced triple-negative breast cancer plasticity and chemoresistanceMohammad Jalalirad, Tufia C Haddad, Jeffrey L Salisbury, et al.
NPJ Breast Cancer|January 20, 2022
Automated quantification of levels of breast terminal duct lobular (TDLU) involution using deep learningThomas de Bel, Geert Litjens, Joshua Ogony, et al.
Pageof 12